CD28 and lymphoma: Pre-clinical data showed that CD28 co-stimulation and co-expression of IL-15 yielded the best CAR cell durability, relocation to tumor sites, and tumor control in murine neuroblastoma and lymphoma models, while inducing no symptoms of GvHD.